Loading
Latest filing published 22 Mar 2022 for Adamis Pharmaceuticals Corp, €1,989.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by David C. Benedicto on record concern Adamis Pharmaceuticals Corp, in the capacity of finance chief. The record holds 2 filings, for trades running from 1 December 2021 to 18 March 2022.
On the market, this insider has only sold: 2 sales, €11k in total. So far in 2022, the count stands at no purchases and 1 sale.
The newest entry dates from 22 March 2022: an open-market sale of €1,989, in Adamis Pharmaceuticals Corp. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations